Fulgent Genetics, Inc.

NASDAQ:FLGT

Medical - Diagnostics & Research

Healthcare
$25.13 +1.89%

+$0.33 today

Market cap
$702.11M
Beta
0.92
P/E (TTM)
-7.5
EPS (TTM)
-$2.39
52W Low $13.46High $31.04

Volume 0.39M

Average 0.55M

FLGT Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Fulgent Genetics, Inc.NASDAQ: FLGT

Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026

Accumulated OCI rises 4.6% from a year ago

Accumulated OCI stood at $4.54M at the end of Q1 FY2026, up 4.6% from a year earlier and down 39.6% from the prior quarter.

Context

  • Accumulated OCI amounted to 0.4% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Accumulated OCI increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +4.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.54M-39.6% QoQ
Last fiscal yearDec 2025
$7.51M+2141.3% YoY
Year agoMar 2025
$4.34M+4.6% since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.6%——
1 year+2141.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
7.51M USD
Year-over-year change
+2141.3%

Accumulated OCI vs competitors

How FLGT compares with its peers on the latest reported figures

  • FLGT's Mar 2026 Accumulated OCI of $4.54M is the highest of the 8 companies compared; the peer median is -$70K.
  • Its year-over-year change of +4.6% is the 3rd highest of 7, against a peer median of -39.2%.
  • Accumulated OCI amounts to 0.4% of total assets for FLGT, versus a peer median of 0.1%.
FLGT Competitors Peer median
Accumulated OCI for FLGT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
FLGTFulgent Genetics, Inc.Mar 2026$4.54M +4.6%—0.4%
MYGNMyriad Genetics, Inc.Mar 2026$700K +216.7%—0.1%
WGSGeneDx Holdings Corp.Jun 2026$342K -57.9%—0.1%
NEONeoGenomics, Inc.Jun 2026$4K -86.2%—0.0%
PSNLPersonalis, Inc.Mar 2026-$70K -288.9%—0.0%
NTRANatera, Inc.Jun 2026-$108K +62.4%—0.0%
BLLNBillionToOne, Inc.Jun 2026-$1.79M ——0.2%
GHGuardant Health, Inc.Sep 2026-$5.13M -20.5%—0.3%
FRNMFreenome, Inc. Common stock—— ———
Peer median (excluding FLGT) -$70K-39.2%—0.1%

Competitors are the stored peer set for FLGT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents164.89M79.51M97.47M55.14M50.19M
Short-term Investments285.61M446.73M326.68M202.96M285.88M
Net Receivables143.3M75.11M57.45M77.03M91.61M
Inventory12.21M4.28M5.83M8.38M10.6M
Other Current Assets00000
Total Current Assets611.96M627.87M507.85M353.57M550.49M
Property, Plant & Equipment (Net)62.29M81.35M83.46M105.55M112.55M
Goodwill50.9M143.03M22.06M22.06M25.08M
Intangible Assets35.91M150.64M143.05M134.98M133.28M
Long-term Investments507.01M339.03M444.01M570.35M369.27M
Tax Assets00000
Other Non-current Assets10.65M44.12M34.9M33.46M22.86M
Total Non-current Assets666.76M758.18M727.48M866.39M663.04M
Total Assets1.28B1.39B1.24B1.22B1.21B
Account Payables20.49M23.09M15.36M18.36M18.65M
Short-term Debt21.28M20.64M1.18M412K476K
Tax Payables787K000107.1M
Deferred Revenue34.38M14.09M25.57M29.84M31.78M
Other Current Liabilities10.68M5.3M6.42M9.89M10.46M
Total Current Liabilities105.31M88.11M73.02M72.9M84.97M
Long-term Debt03.37M2.96M2.49M1.96M
Deferred Tax Liabilities007.96M6.37M6.94M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.53M15.9M10.95M4.92M9.17M
Total Non-current Liabilities7.53M28.07M29.02M17.91M21.84M
Total Liabilities112.84M116.18M102.04M90.81M106.81M
Common Stock3K3K3K3K3K
Retained Earnings657.6M801M633.18M590.47M529.95M
Accumulated OCI(759K)(20.9M)1.21M(368K)7.51M
Other Stockholders Equity00000
Minority Interest7.13M3.19M(2.82M)(4.07M)(5.27M)
Total Equity1.17B1.27B1.13B1.13B1.11B
Total Debt21.28M38.94M15.25M8.47M7.68M
Net Debt(143.61M)(40.57M)(82.22M)(46.68M)(42.52M)

Fulgent Genetics, Inc.

NASDAQ:FLGT

Intrinsic Alpha fair value

Locked

Current Price

$25.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.